Wallace Ryan M, Pees Anna, Blanton Jesse B, Moore Susan M
Poxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Rabies Laboratory, Kansas State Veterinary Diagnostic Laboratory, Kansas State University Rabies Laboratory, Manhattan, Kansas, United States of America.
PLoS Negl Trop Dis. 2017 Jul 31;11(7):e0005761. doi: 10.1371/journal.pntd.0005761. eCollection 2017 Jul.
Ensuring the adequacy of response to rabies vaccination in dogs is important, particularly in the context of pet travel. Few studies have examined the factors associated with dogs' failure to achieve an adequate antibody titer after vaccination (0.5 IU/ml). This study evaluated rabies antibody titers in dogs after primary vaccination. Dogs under one year of age whose serum was submitted to a reference laboratory for routine diagnostics, and which had no prior documented history of vaccination were enrolled (n = 8,011). Geometric mean titers (GMT) were calculated and univariate analysis was performed to assess factors associated with failure to achieve 0.5 IU/mL. Dogs vaccinated at >16 weeks of age had a significantly higher GMT compared to dogs vaccinated at a younger age (1.64 IU/ml, 1.57-1.72, ANOVA p < 0.01). There was no statistical difference in GMT between dogs vaccinated <12 weeks and dogs vaccinated 12-16 weeks (1.22 IU/ml and 1.21 IU/ml). The majority of dogs failed to reach an adequate titer within the first 3 days of primary vaccination; failure rates were also high if the interval from vaccination to titer check was greater than 90 days. Over 90% of dogs that failed primary vaccination were able to achieve adequate titers after booster vaccination. The ideal timing for blood draw is 8-30 days after primary vaccination. In the event of a failure, most dogs will achieve an adequate serologic response upon a repeat titer (in the absence of booster vaccination). Booster vaccination after failure provided the highest probability of an acceptable titer.
确保犬类对狂犬病疫苗接种的反应充分很重要,尤其是在宠物旅行的背景下。很少有研究探讨与犬类接种疫苗后未能达到足够抗体滴度(0.5 IU/ml)相关的因素。本研究评估了初次接种疫苗后犬类的狂犬病抗体滴度。将血清提交至参考实验室进行常规诊断、且无先前疫苗接种记录的一岁以下犬只纳入研究(n = 8,011)。计算几何平均滴度(GMT)并进行单因素分析,以评估与未能达到0.5 IU/mL相关的因素。与较年幼时接种疫苗的犬只相比,16周龄以上接种疫苗的犬只GMT显著更高(1.64 IU/ml,1.57 - 1.72,方差分析p < 0.01)。12周龄以下接种疫苗的犬只与12 - 16周龄接种疫苗的犬只之间的GMT无统计学差异(分别为1.22 IU/ml和1.21 IU/ml)。大多数犬只在初次接种疫苗后的前3天内未能达到足够滴度;如果从接种疫苗到滴度检查的间隔大于90天,失败率也很高。初次接种疫苗失败的犬只中,超过90%在加强免疫后能够达到足够滴度。采血的理想时间是初次接种疫苗后8 - 30天。如果出现失败情况,大多数犬只在重复检测滴度时(在未进行加强免疫的情况下)将获得足够的血清学反应。失败后进行加强免疫提供了获得可接受滴度的最高概率。